Eikon Therapeutics Inc (EIKN)

May 21, 2026

Eikon to present clinical data on three cancer programs at ASCO - Investing.com UK

May 21, 2026

May 21, 2026

Eikon Therapeutics to present six abstracts on cancer drug trials at 2026 ASCO meeting - Pluang

May 21, 2026

May 21, 2026

Eikon Therapeutics Announces Presentation of Advanced Clinical Data at 2026 ASCO Annual Meeting - Quiver Quantitative

May 21, 2026

May 21, 2026

Eikon Therapeutics Announces Availability of Six Abstracts - GlobeNewswire

May 21, 2026

May 21, 2026

EIKN SEC FilingsEikon Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

May 21, 2026

May 20, 2026

IPO Tracker 2026: Parabilis follows hefty Regeneron deal with IPO push - BioSpace

May 20, 2026

May 15, 2026

Number of shareholders of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView

May 15, 2026

May 15, 2026

Innovation Endeavors reports 3.37M shares in Eikon Therapeutics (EIKN) - Stock Titan

May 15, 2026

May 15, 2026

BofA Securities Maintains Eikon Therapeutics(EIKN.US) With Buy Rating, Maintains Target Price $34 - Moomoo

May 15, 2026

May 15, 2026

EIKN Should I Buy - Intellectia AI

May 15, 2026

May 13, 2026

Roger Perlmutter holds 2.89M shares of Eikon Therapeutics (NASDAQ: EIKN) - Stock Titan

May 13, 2026

May 13, 2026

Eikon Therapeutics, Inc.Common Stock (Nasdaq:EIKN) Stock Quote - FinancialContent

May 13, 2026

May 12, 2026

Wedbush Maintains Eikon Therapeutics(EIKN.US) With Sell Rating, Cuts Target Price to $5 - Moomoo

May 12, 2026

May 12, 2026

Wedbush Cuts Price Target on Eikon Therapeutics to $5 From $7, Keeps Underperform Rating - marketscreener.com

May 12, 2026

May 12, 2026

Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates - Sahm

May 12, 2026

May 12, 2026

Zebra Technologies, Vishay Precision Group, Quantum Computing, Aramark And Other Big Stocks Moving Higher On Tuesday - Sahm

May 12, 2026

May 11, 2026

Eikon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 11, 2026

May 11, 2026

IPO cash lifts Eikon Therapeutics (NASDAQ: EIKN) to $596M - Stock Titan

May 11, 2026

May 11, 2026

Eikon Therapeutics (Nasdaq: EIKN) details Q1 loss and ASCO 2026 data plans - Stock Titan

May 11, 2026

May 11, 2026

Press Release: Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates - Moomoo

May 11, 2026

May 06, 2026

FMR LLC holds 3.84M EIKON Therapeutics shares (NASDAQ: EIKN) - Stock Titan

May 06, 2026

May 02, 2026

Eikon Therapeutics prices upsized IPO at $18 per share By Investing.com - Investing.com Nigeria

May 02, 2026

Apr 29, 2026

[SCHEDULE 13G] Eikon Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Apr 29, 2026

Apr 28, 2026

Domino's Posts Downbeat Q1 Results, Joins Real Brokerage And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm

Apr 28, 2026

Apr 27, 2026

Merck reportedly eyeing $30M stake in Eikon Therapeutics’ IPO - MSN

Apr 27, 2026

Apr 27, 2026

Merck veteran-led Eikon seeks $908M valuation in US IPO - MSN

Apr 27, 2026

Apr 20, 2026

Should I be cautious with Eikon Therapeutics (EIKN) stock today (Market Focus) 2026-04-20Most Discussed Stocks - Xã Châu Thành

Apr 20, 2026

Apr 12, 2026

ETFs Investing in Eikon Therapeutics, Inc. Stocks - TradingView

Apr 12, 2026

Apr 12, 2026

EIKN: Eikon Therapeutics, Inc.Comparison to Industry - Zacks Investment Research

Apr 12, 2026

Apr 12, 2026

All News for EIKN : Eikon Therapeutics, Inc. - Zacks Investment Research

Apr 12, 2026

Apr 12, 2026

EIKN : Eikon Therapeutics, Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research

Apr 12, 2026

Apr 11, 2026

Eikon Therapeutics, Inc. News — NASDAQ:EIKN - TradingView

Apr 11, 2026

Apr 11, 2026

EIKN Forecast — Price Target — Prediction for 2027 - TradingView

Apr 11, 2026

Apr 11, 2026

Diluted shares outstanding of Eikon Therapeutics, Inc. – BX:EIKN - TradingView — Track All Markets

Apr 11, 2026

Apr 11, 2026

Number of employees of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView

Apr 11, 2026

Apr 11, 2026

Eikon Therapeutics, Inc. Statistics – BX:EIKN - TradingView — Track All Markets

Apr 11, 2026

Apr 10, 2026

EIKN Price Today: Eikon Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Apr 10, 2026

Apr 09, 2026

IPO market strengthens in Q1 2026 as biopharma financings reach $22.82B - BioWorld News

Apr 09, 2026

Apr 01, 2026

Should I buy Eikon Therapeutics, Inc. (EIKN) - Zacks Investment Research

Apr 01, 2026

Mar 31, 2026

EIKN Analyst Rating Reiterated at Underperform by Wedbush | EIKN Stock News - GuruFocus

Mar 31, 2026

Mar 30, 2026

Eikon Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Mizuho reiterates Eikon Therapeutics stock rating on pipeline update By Investing.com - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

Mizuho reiterates Eikon Therapeutics stock rating on pipeline update - Investing.com

Mar 30, 2026

Mar 30, 2026

IPO Tracker 2026: Biotech Mega-Rounder Kailera Seeks IPO - BioSpace

Mar 30, 2026

Mar 30, 2026

Eikon Therapeutics Reports 2025 Financial Results, Upsized IPO, and Key Clinical Pipeline Progress - Minichart

Mar 30, 2026

Mar 30, 2026

Eikon Therapeutics Reports Q4 and Full Year 2025 Results, Provides Clinical Updates - National Today

Mar 30, 2026